MENU
PBPH
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

PBPH stock forecast, quote, news & analysis

The investment seeks to track the performance, before fees and expenses, of the BITA Global Pharma and Biotech Select Index... Show more

Category: #Health
PBPH
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for PBPH with price predictions
Oct 01, 2026

PBPH in -2.58% downward trend, sliding for three consecutive days on October 01, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where PBPH declined for three days, in 33 of 41 cases, the price declined further within the following month. The odds of a continued downward trend are 80%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for PBPH moved out of overbought territory on August 26, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 6 similar instances where the indicator moved out of overbought territory. In 4 of the 6 cases, the stock moved lower in the following days. This puts the odds of a move lower at 67%.

The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PBPH as a result. In 11 of 18 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.

The Moving Average Convergence Divergence Histogram (MACD) for PBPH turned negative on September 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 7 similar instances when the indicator turned negative. In 2 of the 7 cases the stock turned lower in the days that followed. This puts the odds of success at 29%.

PBPH moved below its 50-day moving average on October 01, 2026 date and that indicates a change from an upward trend to a downward trend.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a +0.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where PBPH advanced for three days, in 36 of 43 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

PBPH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 27 of 28 cases where PBPH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), Moderna (NASDAQ:MRNA), Regeneron Pharmaceuticals (NASDAQ:REGN).

Industry description

The investment seeks to track the performance, before fees and expenses, of the BITA Global Pharma and Biotech Select Index. The fund uses a “passive management” approach to track the performance, before fees and expenses, of the index. The index is constructed using a rules-based methodology that identifies companies in the pharmaceutical and/or biotechnology industries with publicly traded ordinary shares listed on major stock exchanges in developed markets, as classified by BITA GmbH. Under normal circumstances, the fund will invest at least 80% of the fund’s net assets in component securities that make up the index. The fund is non-diversified.

Market Cap

The average market capitalization across the Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) ETF is 217.1B. The market cap for tickers in the group ranges from 7.57B to 1.06T. LLY holds the highest valuation in this group at 1.06T. The lowest valued company is IONS at 7.57B.

High and low price notable news

The average weekly price growth across all stocks in the Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) ETF was 14%. For the same ETF, the average monthly price growth was 25%, and the average quarterly price growth was 281%. UTHR experienced the highest price growth at 21%, while INSM experienced the biggest fall at -11%.

Volume

The average weekly volume growth across all stocks in the Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) ETF was -13%. For the same stocks of the ETF, the average monthly volume growth was -15% and the average quarterly volume growth was -3%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 39
P/E Growth Rating: 46
Price Growth Rating: 46
SMR Rating: 56
Profit Risk Rating: 45
Seasonality Score: 16 (-100 ... +100)
View a ticker or compare two or three
PBPH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Category
Health
Address
United States
Phone
N/A
Web
N/A
PBPH in -2.58% downward trend, sliding for three consecutive days on October 01, 2026